Skip to main content
TipRanks
Go Ultimate75% OFF

PT Indofarma Tbk Class B (INAF) Financial Statements

PT Indofarma Tbk Class B Financial Overview

PT Indofarma Tbk Class B's market cap is currently Rp390.51B. The company's EPS TTM is Rp1.79; its P/E ratio is -6.46; and it has a dividend yield of 0.50%. PT Indofarma Tbk Class B has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Jun 24Mar 23Dec 21
Income Statement
Total RevenueRp 151.55BRp 210.38BRp 523.60BRp 1.14TRp 2.90T
Gross ProfitRp -19.53BRp -37.51BRp -171.96BRp -110.11BRp 451.65B
Operating IncomeRp -208.22BRp -253.73BRp -603.46BRp -479.54BRp 51.98B
EBITDARp -195.04BRp -234.19BRp -581.38BRp -479.11BRp 86.68B
Net IncomeRp -77.99BRp -334.49BRp -720.99BRp -428.49BRp -37.57B
Balance Sheet
Cash & Short-Term InvestmentsRp 5.69BRp 10.11BRp 17.07BRp 308.75BRp 415.81B
Total AssetsRp 535.99BRp 618.16BRp 759.83BRp 1.53TRp 2.01T
Total DebtRp 700.28BRp 738.98BRp 701.76BRp 627.21BRp 604.84B
Net DebtRp 694.60BRp 728.86BRp 684.68BRp 357.46BRp 224.02B
Total LiabilitiesRp 1.24TRp 1.76TRp 1.56TRp 1.45TRp 1.50T
Stockholders' EquityRp -706.94BRp -1.14TRp -804.13BRp 86.36BRp 508.30B
Cash Flow
Free Cash FlowRp -209.89BRp -22.08BRp -194.84BRp -89.42BRp 71.50B
Operating Cash FlowRp -209.89BRp -21.65BRp -190.10BRp -75.95BRp 92.90B
Investing Cash FlowRp 0.00Rp -319.81MRp -4.68BRp -13.40BRp -114.41B
Financing Cash FlowRp 206.32BRp 14.98BRp -57.85BRp 13.33BRp 244.15B

Currency in IDR

PT Indofarma Tbk Class B Earnings and Revenue History

-2T02T4T-200 %-100 %0 %100 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

PT Indofarma Tbk Class B Liabilities to Assets

0800B1.6T2.4T0 %100 %200 %300 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

PT Indofarma Tbk Class B Cash Flow

-300B-200B-100B0100B200B300B201720182019202020212022202320242025OperatingInvestingFinancing

PT Indofarma Tbk Class B Forecast EPS vs Actual EPS

-40-30-20-10010Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss